[L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
D000236:Adenoma / Q000097:blood; D000328:Adult; D000818:Animals; D000906:Antibodies / Q000032:analysis; D013956:Antithyroid Agents / Q000627:therapeutic use; D005260:Female; D006111:Graves Disease / Q000097:blood* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D006801:Humans; D007457:Iodine Radioisotopes; D008135:Long-Acting Thyroid Stimulator / Q000097:blood*; D008297:Male; D008722:Methods; D051379:Mice; D008875:Middle Aged; D009929:Organ Size; D012008:Recurrence; D013961:Thyroid Gland / Q000473:pathology; D013964:Thyroid Neoplasms / Q000097:blood; D013965:Thyroidectomy; D013974:Thyroxine
D000906:Antibodies; D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D008135:Long-Acting Thyroid Stimulator; D013974:Thyroxine
Activité L.A.T.S. au cours de l'hyperthyroïdie. A propos de 143 maladies de Basedow